Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B Cell Lymphoma

Published:2014-12 Issue:12 Volume:20 Page:1905-1911
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Fruchart Christophe,Tilly Hervé,Morschhauser Franck,Ghesquières Hervé,Bouteloup Marie,Fermé Christophe,Van Den Neste Eric,Bordessoule Dominique,Bouabdallah Reda,Delmer Alain,Casasnovas René Olivier,Ysebaert Loïc,Ciappuccini Renaud,Briere Josette,Gisselbrecht Christian

Funder

Bayer

Spectrum Pharmaceuticals

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte;Feugier;J Clin Oncol,2005

2. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP;Sehn;Blood,2007

3. Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era;Ziepert;J Clin Oncol,2010

4. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993

5. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era;Gisselbrecht;J Clin Oncol,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores;Contrast Media & Molecular Imaging;2021-04-15

2. Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers;American Journal of Hematology;2018-03-14

3. Resistance to Y-90 Ibritumomab Tiuxetan Therapy;Resistance to Targeted Anti-Cancer Therapeutics;2018

4. Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology;Biology of Blood and Marrow Transplantation;2017-06

5. Pretransplant FDG-PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis;European Journal of Haematology;2017-01-23